You are here:

bemiparin 25,000 IU/ml injection for sub-cutaneous administration (Zibor)

Advice

Following a resubmission

bemiparin 25,000 IU/ml (Zibor) is not recommended for use within NHS Scotland for the treatment of established deep vein thrombosis, with or without pulmonary embolism, during the acute phase.

Greater numbers of patients had a reduction in thrombus size with bemiparin than unfractionated heparin, although bemiparin has not been compared with other low molecular weight heparins.

The manufacturer did not present a sufficiently robust economic analysis to gain acceptance by SMC.

Drug Details

Drug Name: bemiparin 25,000 IU/ml injection for sub-cutaneous administration (Zibor)
SMC Drug ID: 206/05
Manufacturer: Pan Quimica Farmaceutica S.A.
Indication: Deep vein thrombosis with or without pulmonary embolism
BNF Category:
Sub Category: 2.8 Anticoagulants and protamine
Submission Type: Resubmission
Status: Not Recommended
Date Advice Published: 9 July 2007

Archived Advice

Full submission 10 October 2005

Back